HOUSE_OVERSIGHT_028422.jpg

3.24 MB

Extraction Summary

2
People
5
Organizations
2
Locations
3
Events
2
Relationships
4
Quotes

Document Information

Type: Digital content metadata (json format) from an investigation file
File Size: 3.24 MB
Summary

This document, labeled HOUSE_OVERSIGHT_028422, is a JSON data file containing metadata for several New York Times articles delivered via Apple News. The content, primarily dated September 24, 2018, concerns the 2018 New Jersey Senate race between Robert Menendez and former Celgene executive Bob Hugin. It also references a related article about Celgene settling a $280 million fraud lawsuit in 2017.

People (2)

Name Role Context
Robert J. Hugin Former Pharmaceutical Executive, U.S. Senate Candidate
Mentioned in keywords and article summaries as a former executive (of Celgene) running for U.S. Senate in New Jersey ...
Robert Menendez U.S. Senator
Mentioned in keywords and article summaries as being in a Senate election battle against Bob Hugin in New Jersey.

Organizations (5)

Name Type Context
Celgene Corporation
Pharmaceutical company mentioned in keywords. An article summary states they paid $280 million to settle a fraud suit...
New York Times
The publisher of the news articles described in the JSON data.
Food and Drug Administration
Mentioned as a keyword in the article metadata.
AppleNews
Mentioned as the partner for content delivery in the article URLs.
HOUSE_OVERSIGHT
Appears as a footer/label on the document, likely indicating it is part of a file from the House Oversight Committee.

Timeline (3 events)

2017-07-25
An article was published about Celgene paying $280 million to settle a fraud suit over cancer drugs.
Not specified
2018
The Midterm Elections, specifically the U.S. Senate race in New Jersey.
New Jersey
2018-09-24
A New York Times article about Bob Hugin, Celgene, and Robert Menendez was published.
Not specified

Locations (2)

Location Context
The location of the U.S. Senate election battle between Hugin and Menendez.
nyregion
The section of the New York Times website where the articles are hosted.

Relationships (2)

Robert J. Hugin Former Executive Celgene Corporation
The article summary text describes him as 'A Former Pharmaceutical Executive' and the metadata keywords link 'Hugin, Robert J' and 'Celgene Corporation'.
Robert J. Hugin Political Opponents Robert Menendez
The article summaries describe an 'Unexpected Battle for Senate' between them in New Jersey for the 2018 Midterm Elections.

Key Quotes (4)

"Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs"
Source
HOUSE_OVERSIGHT_028422.jpg
Quote #1
"In Deeply Blue New Jersey, an Unexpected Battle for Senate"
Source
HOUSE_OVERSIGHT_028422.jpg
Quote #2
"A Former Pharmaceutical Executive Is Running for U.S. Senate in New Jersey"
Source
HOUSE_OVERSIGHT_028422.jpg
Quote #3
"Get the full New York Times experience"
Source
HOUSE_OVERSIGHT_028422.jpg
Quote #4

Full Extracted Text

Complete text extracted from the document (4,858 characters)

drugs.html?partner=applenews&ad-
keywords=APPLEMOBILE®ion=written_through&asset_id=100000006090758", "range":{"length"
:66,"start":0},"type":"link"}],"identifier":"_anf-body-2", "layout":"related-
link", "role":"body","text": "Celgene to Pay $280 Million to Settle Fraud Suit Over
Cancer Drugs July 25, 2017", "textstyle":"related-
link", "type":"text"},{"identifier":" anf-divider-3", "layout":"ComponentLayout-
10","role":"divider","stroke":{"color":"#e2e2e2"},"type":"line"}, {"additions":[{"URL":"
https://www.nytimes.com/2018/08/05/nyregion/senator-menendez-election-
nj.html?partner=applenews&ad-
keywords=APPLEMOBILE®ion=written through&asset id=100000006090758", "range":{"length"
:58,"start":0},"type":"link"}],"identifier":"anf-body-3", "layout": "related-
link","role":"body","text":"In Deeply Blue New Jersey, an Unexpected Battle for Senate
Aug. 5, 2018", "textstyle":"related-link","type":"text"},{"identifier":"anf-divider-
4", "layout":"ComponentLayout-
10","role":"divider","stroke":{"color":"#e2e2e2"},"type":"line"}, {"additions":[{"URL":"
https://www.nytimes.com/2018/02/13/nyregion/bob-hugin-robert-menendez-senate-new-
jerey.html?partner=applenews&ad-
keywords=APPLEMOBILE®ion=written through&asset id=100000006090758", "range":{"length"
:74,"start":0},"type":"link"}],"identifier":" anf-body-4","layout":"related-
link", "role": "body", "text":"A Former Pharmaceutical Executive Is Running for U.S.
Senate in New Jersey Feb. 13, 2018", "textstyle":"related-
link", "type":"text"}],"identifier":" anf-section-
3","layout":" defaultComponentLayout","role":"section","type":"section"},{"components":
[{"identifier":" anf-heading4-5", "layout":"bottom-banner-
head", "role": "heading4","text": "Get the full New York Times
experience", "textstyle":"bottom-banner-
head", "type":"text"}, {"additions":[{"URL":"https://rvw-
s.tlnk.io/serve?action=click&publisher_id=229811&site_id=50290&my_campaign=AppleNews_iO
SFusion_Footer","range":{"length":61,"start":0},"type":"link"}],"identifier":"_anf-
body-5", "layout":"bottom-banner-body", "role": "body", "style":" anf-cs-3","text":"
.","textstyle":"bottom-banner-body","type":"text"}],"identifier":"anf-container-
4","layout": "ComponentLayout-12","role":"container","style":"anf-cs-
1","type":"container"}],"documentStyle":{"backgroundColor":"#FFFFFF"},"identifier":"100
000006090758", "language":"en","layout": {"columns":8,"gutter":20,"margin":84,"width":102
4}, "metadata":{"campaignData":{"keywords":["Drugs (Pharmaceuticals)","Thalidomide
(Drug)","Prices (Fares, Fees and Rates)", "Midterm Elections (2018)", "Elections,
Senate", "Cancer", "Celgene Corporation", "Food and Drug Administration", "Senate", "Hugin,
Robert J", "New Jersey", "Menendez,
Robert", "Thalomid", "Revlimid"],"section":["nyregion"]},"canonicalURL":"https://www.nyti
mes.com/2018/09/24/nyregion/bob-hugin-celgene-robert-menendez-
senate.html", "dateModified":"2018-09-24T10:09:00.000Z", "datePublished":"2018-09-
24T09:00:01.000Z","generatorName":"papi", "generatorVersion":"v1","thumbnailImageIdentif
ier":"e126e7bde26613f50f2609cb8776d827", "transparentToolbar":false},"resources":{"07ale
24c-f75c-42c9-8bfb-3f5fa1c7fdd2":{"URL": "asset://07a1e24c-f75c-42c9-8bfb-
3f5fa1c7fdd2","classification":"font","fileSize":0,"fontAttributes":{"familyName":"NYTC
heltenhamSH
Regular", "style":"normal","weight":400,"width":"normal"},"fontName":"NYTCheltenhamSH-
Regular", "identifier": "07a1e24c-f75c-42c9-8bfb-3f5fa1c7fdd2","type":"font"}, "0ad0935b-
f58e-48a5-97dd-658a5f3b6d57":{"URL":"asset://0ad0935b-f58e-48a5-97dd-
658a5f3b6d57","classification":"image", "dimensions":{"height":200,"width":300},"fileSiz
e":0,"identifier": "0ad0935b-f58e-48a5-97dd-
658a5f3b6d57","imageIdentifier":"5e5526aaedbd7af8c8bade0a70b11da0","type":"image"},"0c2
33c47-aa6b-4b66-aea0-1986dcb4b9c2":{"URL":"asset://0c233c47-aa6b-4b66-aea0-
1986dcb4b9c2","classification": "font","fileSize":0,"fontAttributes":{"familyName":"NYTF
ranklin
Medium", "style":"normal", "weight":700,"width":"normal"},"fontName":"NYTFranklin-
Bold", "identifier":"0c233c47-aa6b-4b66-aea0-1986dcb4b9c2","type":"font"}, "0e3e5286-
5659-486a-9302-397ba82e9870":{"URL":"asset://0e3e5286-5659-486a-9302-
397ba82e9870","classification":"image", "dimensions":{"height":1365,"width":2048},"fileS
ize":0,"identifier":"0e3e5286-5659-486a-9302-
397ba82e9870","imageIdentifier":"5e5526aaedbd7af8c8bade0a70b11da0","type":"image"},"179
81fab-7743-4c53-a295-e1c4521ed11a":{"URL":"asset://17981fab-7743-4c53-a295-
e1c4521ed11a","classification":"font","fileSize":0,"fontAttributes":{"familyName":"NYTF
ranklin
Medium", "style":"normal", "weight":500,"width":"normal"},"fontName":"NYTFranklin-
Medium", "identifier":"17981fab-7743-4c53-a295-e1c4521ed11a","type":"font"},"1d413a81-
3170-4a92-9bf9-cd09ec717b7c": {"URL": "asset://1d413a81-3170-4a92-9bf9-
HOUSE_OVERSIGHT_028422

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document